Alpha Paradigm Partners, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Alpha Paradigm Partners, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$573.97 - $724.32 $729,515 - $920,610	1,271 Added 895.07%	1,413 $973,000
Q2 2022 Aug 15, 2022	BUY	$548.35 - $738.84 $77,865 - $104,915	142 New	142 $84 Million
Q1 2022 May 16, 2022	SELL	$595.12 - $698.43 $588,573 - $690,747	-989 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$543.48 - $670.97 $120,109 - $148,284	221 Added 28.78%	989 $625 Million
Q3 2021 Nov 15, 2021	SELL	$574.03 - $680.96 $1.56 Million - $1.85 Million	-2,718 Reduced 77.97%	768 $465 Million
Q2 2021 Aug 13, 2021	BUY	$472.8 - $558.54 $1.65 Million - $1.95 Million	3,486 New	3,486 $1.95 Billion

1,516

82.6M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $73.1B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Alpha Paradigm Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Alpha Paradigm Partners, LLC with notifications on news.